Interestingly, administration of the URAT1 inhibitor dotinurad in mice improves hepatic steatosis and insulin resistance induced by a high-fat diet, highlighting the potential role of URAT1 in regulating glucose metabolism (Tanaka et al., 2022). The gene discussed is SLC22A12; the disease is Hepatic steatosis.